Access & reimbursement

A CE Mark Is Not Access

Europe Opens the SMA Gene-Therapy Door Wider

Pregnancy complications demand long-term cardiovascular care

MENA’s cardiometabolic crisis is a stability issue

Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress

Corxel’s oral GLP-1 trial adds momentum. The real question is who these drugs will reach

Chemo Shortages Are Back. So Is Rationing.

Deep learning uncovers a new ECG biomarker for sudden cardiac death

Half of CKM patients go untreated and most fail control
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
